Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3

The present study investigates the presence of vitamin D receptor (VDR) in cells of the rat oligodendrocyte (OL) lineage. VDR transcripts were detected by in situ hybridization in a fraction of rat OL in secondary cultures. The VDR protein was shown to be co‐localized in cells that are also recognized by an anti‐myelin basic protein (MBP) antibody. Likewise, in vivo, VDR‐positive cells were found in the brain white matter, such as the internal capsule of the striatum or the corpus callosum but also in the spinal cord. At least part of these positive cells in vivo correspond to OL, since they were co‐stained by an anti‐carbonic anhydrase II antiserum. Northern blot analyses of the CG‐4 OL cell line demonstrated that the VDR transcripts are already found in the O‐2A precursors. There was a two‐fold increase in the relative abundance of these transcripts in differentiated OL or in type‐2 astrocytes. 1,25‐dihydroxyvitamin D3 [1,25‐(OH)2D3] increased the pool of transcripts encoding its own receptor, the VDR. The hormone also enhanced the abundance of the mRNA of the nerve growth factor (NGF) and of its low‐affinity receptor, the p75NTR protein. By contrast, the hormone had no effect on the levels of MBP or proteolipid protein (PLP) mRNA. This finding suggests that unlike retinoic acid (RA) or thyroid hormone, 1,25‐(OH)2D3 has no regulatory action on the synthesis of myelin proteins. GLIA 31:59–68, 2000. © 2000 Wiley‐Liss, Inc.

[1]  A. Warrington,et al.  The oligodendrocyte and its many cellular processes. , 1993, Trends in cell biology.

[2]  J. Matthieu,et al.  Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice. , 1990, Developmental neuroscience.

[3]  G. Jirikowski,et al.  1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. , 1997, Cellular and molecular biology.

[4]  D. Muir,et al.  CG‐4, A new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type‐2 astrocytes , 1992, Journal of neuroscience research.

[5]  H. DeLuca,et al.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.

[6]  A. Mackay,et al.  Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  M. Somerville,et al.  Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.

[8]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[9]  G. Labourdette,et al.  Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro , 1987, Neuroscience Letters.

[10]  G. Miller,et al.  Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. , 1996, Endocrinology.

[11]  H. DeLuca,et al.  Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Carswell,et al.  Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.

[13]  J. Vallat,et al.  Platelet‐derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin‐like membranes repair in vitro , 1996, Glia.

[14]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[15]  W. Rutter,et al.  Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor , 1983, Nature.

[16]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. , 1996, Brain research. Molecular brain research.

[17]  M. Walters Newly identified actions of the vitamin D endocrine system. , 1992, Endocrine reviews.

[18]  P. Brachet,et al.  1,25 Dihydroxyvitamin D3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis , 1996, Journal of neuropathology and experimental neurology.

[19]  P. Albert,et al.  Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. , 1995, Journal of immunology.

[20]  B. Zalc,et al.  Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition , 1996, Glia.

[21]  J. Puymirat,et al.  Transient expression of 3,5,3′‐triiodothyronine nuclear receptors in rat oligodendrocytes: In vivo and in vitro immunocytochemical studies , 1994, Journal of neuroscience research.

[22]  M. Noble,et al.  Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. , 1996, Developmental biology.

[23]  J. Adams,et al.  1,25‐Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein‐specific T cell clone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  N. Ibarrola,et al.  Stimulation of the myelin basic protein gene expression by 9-cis-retinoic acid and thyroid hormone: activation in the context of its native promoter. , 1999, Brain research. Molecular brain research.

[25]  J. Pike,et al.  Vitamin D3 receptors: structure and function in transcription. , 1991, Annual review of nutrition.

[26]  R. Skoff,et al.  Oligodendrocytes in female carriers of the jimpy gene make more myelin than normal oligodendrocytes , 1995, The Journal of comparative neurology.

[27]  G. Labourdette,et al.  Oligodendroglia content of glial cell primary cultures, from newborn rat brain hemispheres, depends on the initial plating density , 1980, Neuroscience Letters.

[28]  J. Puymirat,et al.  Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone , 1997, Glia.

[29]  H. DeLuca,et al.  Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.

[30]  A. Rodríguez-Peña,et al.  Oligodendrocyte development and thyroid hormone. , 1999, Journal of neurobiology.

[31]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[32]  M. Ghandour,et al.  Cultures from rat brain hemispheres enriched in oligodendrocyte-like cells , 1979, Brain Research.

[33]  K. Ozono,et al.  Perspectives: The genomic mechanism of action of 1,25‐dihydroxyvitamin D3 , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  B. Pettmann,et al.  Retinoic acid regulates the development of oligodendrocyte precursor cells in vitro , 1994, Journal of neuroscience research.

[35]  J. Vallat,et al.  Investigation of myelination in vitro: polar lipid content and fatty acid composition of myelinating oligodendrocytes in rat oligodendrocyte cultures , 1990, Neurochemistry International.

[36]  S. Brimijoin,et al.  1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.

[37]  M. Galligan,et al.  Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Labourdette,et al.  UPD-galactose:Ceramide galactosyltransferase activity in dissociated cell cultures from brain hemispheres of newborn rats , 1980, Neuroscience Letters.

[39]  M. Haussler,et al.  Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. , 1993, The Journal of biological chemistry.

[40]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 Regulates the Synthesis of γ‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes , 1999, Journal of neurochemistry.

[41]  J. Puymirat,et al.  Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3′-triiodo-l-thyronine , 1994, Neuroscience Letters.

[42]  N. Bhat,et al.  Cytokine Induction of Inducible Nitric Oxide Synthase in an Oligodendrocyte Cell Line , 1999, Journal of neurochemistry.

[43]  J. Puymirat,et al.  Expression of α and β thyroid receptors during oligodendrocyte differentiation , 1994 .

[44]  P. Brachet,et al.  Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro , 1994, Journal of neuroscience research.

[45]  C. Demerens,et al.  Thyroid hormone receptor isoforms are sequentially expressed in oligodendrocyte lineage cells during rat cerebral development , 1998, Journal of neuroscience research.

[46]  J M Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[47]  C. Campagnoni,et al.  Structure and expression of the mouse myelin proteolipid protein gene , 1987, Journal of neuroscience research.

[48]  H. DeLuca,et al.  Recent advances in the molecular biology of vitamin D action. , 1996, Progress in nucleic acid research and molecular biology.

[49]  H. DeLuca,et al.  A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. de Vellis,et al.  CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. , 1993, Brain research. Molecular brain research.

[51]  M. Saarma,et al.  Regulatory elements and transcriptional regulation by testosterone and retinoic acid of the rat nerve growth factor receptor promoter. , 1992, Gene.

[52]  P. Brachet,et al.  1,25‐dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro , 1998 .

[53]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  E. Brown,et al.  A rapid and simple one step method for isolation of poly(A)+ RNA from cells in monolayer. , 1990, Endocrinology.

[55]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[56]  P. Brachet,et al.  Differential expression of M‐CSF, LIF, and TNF‐α genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D , 1996, Journal of neuroscience research.

[57]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. , 1997, Brain research. Molecular brain research.

[58]  R. Dobrowsky,et al.  Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75 , 1996, Nature.

[59]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Sutcliffe,et al.  p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. , 1988, DNA.

[61]  E. Shooter,et al.  Gene transfer and molecular cloning of the rat nerve growth factor receptor , 1987, Nature.

[62]  T. Kawada,et al.  Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. , 1993, Biochemical and biophysical research communications.

[63]  P. Brachet,et al.  Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25‐dihydroxyvitamin D3 , 1998, Glia.

[64]  M. Atchison,et al.  Small basic proteins of myelin from central and peripheral nervous systems are encoded by the same gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Norman,et al.  Vitamin K-dependent γ-carboxylation of the 1,25-dihydroxyvitamin D3 receptor , 1992 .

[66]  M. Lazar,et al.  A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. , 1994, Development.

[67]  H. Koeffler,et al.  Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. , 1987, The Journal of biological chemistry.

[68]  G. Labourdette,et al.  Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes , 1989, International Journal of Developmental Neuroscience.

[69]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[70]  M. Haussler,et al.  Development of hybridomas secreting monoclonal antibodies to the chicken intestinal 1 alpha,25-dihydroxyvitamin D3 receptor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Noble,et al.  Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[72]  A. Dace,et al.  Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: relationship with the adipogenic action of triiodothyronine. , 1997, Biochemical and biophysical research communications.

[73]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.